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Self-renewal of mouse embryonic stem (ES) 
cells has been studied extensively, which has re-
sulted  in  the  identification  of  growth  factors 
that are able to keep ES cells undifferentiated 
when  cultured  in  vitro  (Smith  and  Hooper, 
1987; Smith, 1991; Ying et al., 2003, 2008; 
Greber et al., 2010). Downstream of the path-
ways activated by these growth factors are the 
core pluripotency regulating transcription fac-
tors Oct3/4, Sox2, Klf4, and Nanog, which 
form  a  self-sustaining  network  (Niwa  et  al., 
2000; Chambers et al., 2003; Mitsui et al., 2003; 
Boyer et al., 2005; Kuroda et al., 2005; Li et al., 
2005; Ivanova et al., 2006; Loh et al., 2006; 
Kim et al., 2008). Introduction of these factors 
in different combinations, including cMyc and 
lin28, into somatic cells leads to reprogram-
ming and functional conversion into an induced   
pluripotent stem cell (Takahashi and Yamanaka 
2006; Okita et al., 2007; Takahashi et al., 2007; 
Yamanaka 2008).
In vitro cultured mouse ES cells can be dif-
ferentiated  into  any  cell  of  the  mouse  body 
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Despite intense investigation of intrinsic and extrinsic factors that regulate pluripotency, 
the process of initial fate commitment of embryonic stem (ES) cells is still poorly under-
stood. We used a genome-wide short hairpin RNA screen in mouse ES cells to identify 
genes that are essential for initiation of differentiation. Knockdown of the scaffolding 
protein Mek binding protein 1 (Mp1, also known as Lamtor3 or Map2k1ip1) stimulated 
self-renewal of ES cells, blocked differentiation, and promoted proliferation. Fibroblast 
growth factor 4 (FGF4) signaling is required for initial fate commitment of ES cells. Knock-
down of Mp1 inhibited FGF4-induced differentiation but did not alter FGF4-driven prolif-
eration. This uncoupling of differentiation and proliferation was also observed when 
oncogenic Ras isoforms were overexpressed in ES cells. Knockdown of Mp1 redirected FGF4 
signaling from differentiation toward pluripotency and up-regulated the pluripotency-
related genes Esrrb, Rex1, Tcl1, and Sox2. We also found that human germ cell tumors 
(GCTs) express low amounts of Mp1 in the invasive embryonic carcinoma and seminoma 
histologies and higher amounts of Mp1 in the noninvasive carcinoma in situ precursor and 
differentiated components. Knockdown of Mp1 in invasive GCT cells resulted in resistance 
to differentiation, thereby showing a functional role for Mp1 both in normal differentia-
tion of ES cells and in germ cell cancer.
©  2011  Westerman  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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that Stat3 is dispensable for self-renewal (Ying et al., 2008). 
When Stat3-deficient ES cells are grown in medium contain-
ing LIF, this leads to differentiation. Because LIF induces Ras–
Mek–Erk  signaling,  this  indicates  that  in  Stat3-proficient 
cells, Stat3 overrules the differentiation cues given by activa-
tion of the Ras–Mek–Erk pathway.
In addition to the requirement of LIF/Stat3 signaling, it 
was found that serum is required to propagate ES cells to 
prevent neuroectodermal commitment. Serum can be substi-
tuted by Bmp4, showing that the Smad1,5,8 pathway inhibits 
neural commitment (Ying et al., 2003). Furthermore, Bmp4 
has been shown to repress the p38 mitogen-activated protein 
kinase (MAPK) pathway (Qi et al., 2004).
To address which factors contribute to the initial commit-
ment of ES cells to germ layer fates, we performed a genome-
wide  loss  of  function  screen  using  a  short  hairpin  RNA 
(shRNA) approach. We found that shRNA-mediated knock-
down of the scaffolding protein Mp1 inhibits ES cell differen-
tiation, whereas FGF4- or HrasV12-mediated proliferation is 
when placed back into blastocysts (Beddington and Robertson, 
1989) and, therefore, ES cells are named pluripotent. In the 
absence of mouse embryonic fibroblasts, ES cell pluripo-
tency is maintained by the IL-6 family cytokine leukemia in-
hibitory factor (LIF; Smith and Hooper, 1987; Smith et al., 
1988; Williams et al., 1988; Niwa et al., 2009). Stat3 is the 
key downstream target of the LIF pathway, and dominant-
negative Stat3 induces differentiation of ES cells in the 
presence of LIF (Boeuf et al., 1997). Mouse ES cells can be 
maintained pluripotent in the absence of any cytokine signal-
ing in medium that contains the fibroblast growth factor (FGF) 
receptor  inhibitor  SU5402,  and  the  phospho–extracellular 
signal-regulated kinase (Erk) inhibitor PD184352 together 
with  a  pharmacological  inhibitor  of  GSK3,  CHIR99021 
(Ying et al., 2008). This finding highlights the fact that inhi-
bition of the Ras–Mek–Erk pathway is pivotal for prevention 
of differentiation of mouse ES cells (Kunath et al., 2007). 
Moreover,  it  was  shown  that  Stat3-deficient  ES  cells  re-
mained undifferentiated using these three inhibitors, showing 
Figure 1.  shRNA screen for genes influencing mouse ES cell differentiation. Mouse ES cells were retrovirally transduced with a shRNA library 
targeting 16,000 genes (or shGFP specific). Cells were grown in LDM for 1 wk, and this was repeated two times. Colonies remaining after 3 wk were 
pooled, and 300 recovered shRNAs were sequenced. (A) Bar graphs show the absolute number (above bars) of recovered ES colonies after 3 wk of culture. 
The seeding density of the ES cells 1 d after plating is shown on the right. (B–D) The identified shRNAs were reintroduced into mouse ES cells, which were 
grown for one, two, or three replatings. (B) At the indicated time points, cells were stained with AP. (C) Efficiency of target gene knockdown (relative to 
shGFP) was measured by qPCR. (D) Cells in each well were counted and compared with +LIF conditions (100%) after 3 wk of culture. Error bars, standard 
deviation. Data represent two independent experiments. Bar, 100 µm.JEM Vol. 208, No. 13 
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bar graph). The control plates, containing ES cells infected 
with an shRNA against GFP (referred to as shGFP; Table S1), 
gave a low number of colonies (n = 3). The shRNAs were 
recovered by PCR, recloned into the pRetrosuper back-
bone, and sequenced. Sequencing of 300 individual plasmids 
led to identification of 12 putative target genes of these 
shRNAs. A 100% match of each 19-mer was observed with 
the corresponding mRNA. The relative representation of the 
shRNAs, given as the percentage of all hairpins that were re-
covered, is shown in Table 1. The shRNA sequence target-
ing the gene calpain 10 (Capn10) was identified in roughly 
half of the sequences, and for the other shRNAs the relative 
representation ranged from 8 to <1% of the clones. Three of 
the genes have previously been described to be involved in 
differentiation of ES cells, i.e., Ptpn11 (also called Shp-2; 
Burdon et al., 1999), Ephb4 (Wang et al., 2006), and Mllt4 
(myeloid/lymphoid or mixed-lineage leukemia [trithorax 
homologue, Drosophila]; Ikeda et al.,1999), which validates 
our screening strategy. Recovered shRNA sequences are 
given in Tables S3 and S4.
The identified shRNAs were reintroduced into ES cells 
individually to validate the phenotype of each shRNA. Alkaline 
phosphatase (AP) staining was used to visualize the number of 
not affected. Mp1 controls the branching downstream of 
FGF/Ras signaling and thereby regulates pluripotency gene 
transcription. Furthermore, we show that early invasive germ 
cell tumors (GCTs; seminoma [Sem] and embryonal carci-
noma) have low expression levels of Mp1, compared with the 
preinvasive stage as well as differentiated components, and this 
low expression contributes to inhibition of differentiation.
RESULTS
A genome-wide screen identifies candidate genes that,  
upon knockdown, maintain pluripotency in the absence of LIF
To gain insight into the early events that regulate the first 
steps of ES cell differentiation, we performed an shRNA-
mediated knockdown screen to inhibit differentiation of ES 
cells in the absence of LIF/Stat3 signaling. For this, we retro-
virally transduced mouse ES cells with an shRNA library   
targeting 16,000 genes (Huang et al., 2009). Cells were sub-
sequently plated at a density that allowed colony outgrowth 
from a single cell (plating density is shown in Fig. 1 A) and 
cells were grown in LIF-depleted medium (LDM) for 1 wk. 
This was repeated two times, allowing a three-fold clonal ex-
pansion. The colonies that were present after 3 wk (n = 61) 
were pooled and genomic DNA was recovered (Fig. 1 A, 
Table 1.  Summary of genes corresponding to the hairpins identified in the ES cell screen
Number shRNA 19mer identified Matching 
gene
Full gene name Hairpin 
identity
Number of 
hairpins out 
of 300
Percentage 
 of 
hairpins
Described 
before?
Reference
1 TAGCGATGTGGTACACAGC Capn10 Calpain 10  19/19 
(100%)
151 50 No
2 TTTGCTTATAAGGTCACTC Fbxl12 F-box and leucine-rich repeat 
protein 12
19/19 
(100%)
24 8.0 No
3 TTGAGTGGCAATGTAACTC Ptpn11 (Shp2) Protein tyrosine phosphatase, 
non-receptor type 11
19/19 
(100%)
19 6.3 Yes Burdon et al., 
1999
4 TTGCTATCCATCTCGTTAC Dusp27 Dual specificity phosphatase 27 19/19 
(100%)
16 5.3 No
5 TATCTGACACAACAATTGC MP1 Mus musculus similar to 
mitogen-activated protein kinase 
kinase 1–interacting protein 1 
(MEK binding partner 1)
19/19 
(100%)
8 2.6 No
6 TTGACCAAGATGTTCCGAG Ephb4 Eph receptor B4 19/19 
(100%)
3 1.0 Yes Wang et al., 
2006
7 TTGAATAAACTTGGTAAAC G0VN5 Mus musculus similar to putative 
pheromone receptor (Go-VN5)
19/19 
(100%)
3 1.0 No
8 CCCATTGAACTGCATACTA Car3 Carbonic anhydrase 3 19/19 
(100%)
2 0.7 No
9 TACTCTCTATAAGCCAGGC Abca12 ATP-binding cassette, sub-family 
A (ABC1), member 12, transcript 
variant 3
19/19 
(100%)
2 0.7 No
10 CATTTATGACTGAACTCTA Ccdc122 Coiled-coil domain containing 
122
19/19 
(100%)
1 0.3 No
11 TACTAAGTAGGGCAGCTTC Mllt4 Myeloid/lymphoid or mixed-
lineage leukemia
19/19 
(100%)
1 0.3 Yes Ikeda et al., 
1999
12 GGATTATATCCATATTCAA Sism Similar to suppressor of initiator 
codon mutations
19/19 
(100%)
1 0.3 No
The total number of hairpins was 234 (78%), with other hairpins numbering 66 (22%), for a grand total of 300 (100%).2678 Mp1 influences pluripotency | Westerman et al.
colonies after 1 wk (Fig. 1 B). Mp1 knockdown 
resulted in a phenotype that was comparable to 
ES cells overexpressing Nanog as indicated by the 
ES morphology, colony size, and positive staining 
for AP (Fig. 2 A). In contrast, knockdown of the 
positive  control  Methyl-CpG  binding  domain 
protein 3 (Mbd3; Kaji et al., 2006; Liang et al., 
2008;  Fig.  2  A)  and  the  previously  described 
Ptpn11 (Burdon et al., 1999; Fig. S1) showed rel-
atively small colonies, indicating that these and 
other hits of the screen, such as shFbxl12 and 
shDusp27, block differentiation but do not nec-
essarily contribute to proliferation. Because of the 
striking phenotype of Mp1 knockdown, we ana-
lyzed the function of this gene in further detail.
Mp1 knockdown results in a block  
in differentiation and a proliferation  
advantage in ES cells
To rule out cell line–specific artifacts, we con-
firmed the inhibitory effect of Mp1 knockdown on differenti-
ation in F1V6.5 and E14/Tg2a ES cell lines (Fig. 2 B). To 
independently test whether Mp1 knockdown leads to a block 
in differentiation in the absence of LIF, we used Nanog-GFP 
reporter ES cells (Fig. 3 A). After knockdown of Mp1 with 
the shRNA recovered from the screen and another shRNA 
(shMp1-G), the Nanog reporter activity was stably maintained 
when compared with the control which showed a clear de-
cline in reporter activity. Knockdowns are shown in Fig. 3 A.
To test whether Mp1 knockdown prevents neuroecto-
dermal differentiation, we cultured ES cells in serum-free me-
dium (N2B27) containing LIF, without Bmp4, according to 
Ying et al. (2003). After a week, cells were replated, the cells 
with Mp1 knockdown stained positive for AP, and immuno-
fluorescence staining showed expression of Oct3/4 (Fig. 3 A 
and not depicted). In contrast, cells infected with the control 
shRNAs formed aggregates that resembled neurospheres. 
ES cells after 1, 2, and 3 wk of consecutive replating at clonal 
density (1,000 cells/cm2), using shGFP as a negative control 
(Fig. 1 B). For each shRNA, the knockdown level was mea-
sured by quantitative PCR (qPCR) using shGFP as a reference 
(Fig. 1 C). Most shRNAs gave a considerable knockdown, 
except for shG0VN5, shSism, and shAbca12, which could in-
dicate that these shRNAs act off-target.
Of the tested 12 putative hits, shFbxl12, shPtpn11, and 
shMp1 stood out as the shRNAs that showed an ES cell mor-
phology after 3 wk of culture without LIF, which resembled 
the morphology of cells expressing pCAG-Nanog or cells that 
were grown in the presence of LIF (Fig. 2 A and Fig. S1). 
Transduction of ES cells with the shRNA against the scaf-
folding protein Mek binding protein 1 (Mp1, Lamtor3, 
Map2k1ip1) resulted in higher cell numbers per well after   
3 wk when compared with the other hits. (Fig. 1 D; and 
growth curves are shown in Fig. 2 A and Fig. S1). The control 
plates containing shGFP showed a rapid decline in AP-positive 
Figure 2.  Knockdown of Mp1 in E14T ES cells re-
sembles Nanog overexpression or growth in the pres-
ence of LIF. (A) Growth curves (left) of ES cells infected 
with shMp1, the negative control shGFP, or the positive 
control shMbd3 when grown in LDM for 3 wk. After 3 wk, 
colonies were stained for AP. Additional positive controls 
were transfection with pCAG-Nanog or addition of LIF. 
Knockdown of Mbd3, as measured with qPCR, is shown 
below the Mbd3 growth curve. (B) AP staining shows that 
knockdown of Mp1 in two other ES cell lines, E14/Tg2a and 
F1V6.5, inhibits differentiation when these cells were grown 
in LDM for 2 wk. Knockdown was performed using the 
shRNA identified from the library (shMp1-Lib) and an ad-
ditional shRNA indicated by shMp1-G. Negative controls 
were shGFP and a shRNA containing a random sequence 
(shRnd1). Western blot analysis shows the knockdown levels 
of Mp1 in these cell lines (right). Data represent at least two 
independent experiments. Error bars, standard deviation.  
Bar, 100 µm.JEM Vol. 208, No. 13 
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Nanog-GFP–positive  ES  cells  had 
an enhanced proliferation rate upon 
knockdown of Mp1 compared with 
undifferentiated  ES  cells  that  were 
infected with a control shRNA (P < 
0.001). Cells that were differentiated, 
i.e., cells that had a low Nanog-GFP 
reporter activity, showed no Mp1-dependent proliferation 
advantage. These data show that Mp1 knockdown inhibits 
differentiation and leads to a proliferation advantage restricted 
to ES cells.
Differentiation induced by constitutive forms of Ras  
and Raf can be inhibited by Mp1 knockdown
Ras–Mek–Erk signaling plays a pivotal role in the initiation 
of differentiation of ES cells. To analyze the role of activa-
tors of the FGF–Mek–Erk pathway in ES cells, we analyzed 
the  function  of  different  constitutive  active  isoforms  of 
HRasV12, KRasV12, and Braf  V600 in ES cells. The over-
expression of HrasV12 in both ES cells and F9 mouse em-
bryonic carcinoma (EC) cells has been shown to induce 
differentiation, in contrast to Eras, KrasV12, and NrasV12, 
which primarily control proliferation of ES cells (Eras) or 
their derived endosomal lineages (KrasV12 and NrasV12; 
Takahashi et al., 2003; Quinlan et al., 2008). We analyzed 
whether Mp1 could interfere with this differentiation (Fig. 4, 
A and B).
After attachment to laminin-coated plates, immunofluores-
cence microscopy showed that these cells had down-regulated 
OCT3/4 and expressed nestin, an early neural marker, con-
firming that the control cells had indeed gone into a neuro-
ectodermal cell fate. However, because 50% of the ES cells 
loose their expression of Oct4, we cannot rule out that 
knockdown of Mp1 inhibits neuroectodermal differentiation 
and does not necessarily depend only on Mp1-mediated plu-
ripotency regulation.
We measured whether the knockdown of Mp1 led to a 
proliferation advantage. Mp1 knockdown showed exponen-
tial proliferation in the absence of LIF in contrast to the con-
trol shGFP, which revealed a rapid decrease in proliferation 
after 2 wk of culture (Fig. 3 B, top). A similar result was ob-
tained in the presence of LIF, albeit to a lesser extent (Fig. 3 B, 
middle). To see whether this proliferation advantage was re-
stricted to undifferentiated ES cells, we FACS sorted Nanog-
GFP reporter ES cells that were differentiated for 4 d on 
LDM and analyzed BrdU incorporation in these sorted popula-
tions (Fig. 3 B, bottom). This showed that undifferentiated 
Figure 3.  Knockdown of Mp1 inhibits 
differentiation and stimulates prolifera-
tion in ES cells. (A) FACS plot of E14T-
Nanog-GFP reporter ES cells containing a 
randomly targeted Nanog promoter frag-
ment that drives GFP expression. Reporter 
activity was assayed after growing the cells 
in LDM for 4 d after knockdown of Mp1 or 
after using a control shRNA containing a 
random sequence (shRnd1). Knockdown was 
performed using the shRNA identified from 
the library (shMp1-Lib) and an additional 
shRNA indicated by shMp1-G. Positive con-
trol cells were grown in the presence of LIF 
for 4 d. Knockdown of Mp1 was confirmed 
by qPCR (bottom) and Western blotting 
(middle right). Knockdown of Mp1 in the 
absence of Bmp4 maintains OCT3/4 expres-
sion (positive fraction is shown in red) while 
suppressing Nestin expression (positive frac-
tion is shown in green). Positive controls 
were: undifferentiated ES cells and subven-
tricular zone neural stem cells. (B) Knock-
down of Mp1 gives a proliferation advantage 
in the absence (top) and presence (middle) of 
LIF in the total population of seeded cells, 
but also in Nanog-GFP–positive ES cells that 
were cultured 4 d without LIF (bottom). Error 
bars, standard deviation. Data represent two 
independent experiments.2680 Mp1 influences pluripotency | Westerman et al.
FGF4-dependent differentiation and proliferation, we used 
FGF4-deficient ES cells (Wilder et al., 1997). These cells indeed 
maintained their pluripotency under differentiation-inducing 
conditions (LDM). Addition of FGF4 to these FGF4/ ES 
cells resulted in strong proliferation and differentiation (com-
pare growth curves and AP stainings in Fig. 5 A), in agree-
ment with the earlier findings of Kunath et al. (2007).
We analyzed the effect of FGF4 signaling onto Mp1-
dependent differentiation. For this, FGF4/ ES cells with Mp1 
knockdown (Fig. 5 B) were stimulated with increasing doses of 
FGF4 in the absence of LIF, which resulted in increasing num-
bers of undifferentiated AP-positive colonies (Fig. 5 C). In con-
trast, the control shRNA-infected cells did not show self-renewal 
upon stimulation with FGF4 and detached from the plate within 
6 d of culture. This shows that FGF4 stimulates self-renewal upon 
knockdown of Mp1, instead of driving differentiation.
The previous data show that Mp1 levels control self-
renewal versus differentiation in ES cells, and therefore we 
reasoned that Mp1 might be induced upon removal of LIF or 
BMP4, thereby enabling differentiation. However, when ei-
ther of these growth factors was removed from the medium, 
no up-regulation of Mp1 was observed (unpublished data). A 
rather small decrease was seen when cells started differentiation 
HrasV12 overexpression strongly induced differentiation 
both in the presence of high LIF and at lower concentrations 
of LIF within 5 d. Upon knockdown of Mp1, HrasV12-
induced differentiation was largely inhibited, especially in the 
presence of LIF. When KrasV12 was overexpressed however, 
this led to major expansion of the ES cells at lower LIF con-
centrations. Besides this expansion of ES cells, a lower amount 
of differentiation was observed compared with HrasV12, 
and this differentiation was inhibited by Mp1 knockdown at 
lower concentrations of LIF. Braf  V600-induced differentiation 
was inhibited by Mp1 knockdown, and Braf  V600 overex-
pression did not show any proliferation phenotype compa-
rable to that of KrasV12. This shows that overexpression of 
HrasV12 and Braf  V600 lead primarily to differentiation which 
can be inhibited by Mp1 knockdown.
Mp1 knockdown uncouples FGF4-mediated proliferation 
and differentiation and results in activation of Esrrb, Zfp42, 
Tcl1, and SOX2 and enhanced PI3K signaling
FGF4-deficient ES cells do not differentiate under serum-
free conditions because of lack of endogenous sources for 
Ras–Mek–Erk activation (Kunath et al., 2007; Ying et al., 
2008). To study whether Mp1 knockdown interferes with 
Figure 4.  Ras/Raf-induced differentiation can be inhibited by Mp1 knockdown. (A) AP stainings show the effect of overexpression of constitutively 
active forms of Ras/Raf on ES cells combined with or without knockdown of Mp1. (B) The red bars in the histogram show the relative surface covered by 
AP-positive cells with an ES cell morphology and the gray bars show the surface covered by AP-negative cells with a differentiated morphology. When 
constitutively active Hras-V12 was overexpressed, this led to a strong induction of differentiation. Knockdown of Mp1 was, for the most part, able to inhibit 
this differentiation capacity of HrasV12. When constitutively active Kras-V12 was overexpressed, the inhibition of differentiation was less pronounced, and 
this weaker effect was inhibited by Mp1 knockdown. Overexpression of the constitutively active form of Braf, Braf   V600, led to strong differentiation, which 
was comparable to HrasV12. This strong differentiation effect could be inhibited largely by Mp1 knockdown. When control cells were transduced with an 
empty vector, differentiation was observed only in the absence of LIF. Data represent more than two independent experiments. Bar, 100 µm.JEM Vol. 208, No. 13 
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induce differentiation, and that Mp1 does not repress LIF/
STAT3 signals.
To identify which genes are important for the mainte-
nance of self-renewal in ES cells with Mp1 knockdown after 
induction with FGF4, we performed microarray analysis on 
day 3 after induction with FGF4 (Fig. 5 D). We found that   
a panel of pluripotency determinators were regulated by 
FGF4 upon knockdown of Mp1, i.e., Esrrb, Zfp42, Tcl1, 
and Sox2. These genes were not activated by FGF4 when the 
control shRNAs were used (Fig. 5 D, compare left and right). 
in the absence of LIF. We argued that overexpression of Mp1 
or  its  heterodimerization  partner  p14  (Wunderlich  et  al., 
2001; Teis et al., 2002, 2006) might induce differentiation. 
When these genes were lentivirally expressed, no differentia-
tion was observed in ES cells or F9 EC cells (unpublished 
data). Alternatively, knockdown of Mp1 might stimulate the 
activation of the JAK–STAT3 pathway; however, we did not 
observe enhanced p-STAT3 levels (unpublished data). These 
experiments show that Mp1 is not negatively controlled by 
LIF or BMP4, that Mp1 overexpression is insufficient to 
Figure 5.  Mp1 knockdown uncouples proliferation and differentiation of ES cells in the absence of LIF. (A) Growth curve and graphs showing 
that addition of FGF4 to FGF4-deficient ES cells leads to both proliferation and differentiation. (B) qPCR showing Mp1 knockdown in FGF4-deficient ES 
cells. (C) FGF4-deficient ES cells were infected with Mp1 shRNAs or control shRNAs and cells were subsequently treated with increasing doses of FGF4 to 
induce differentiation in the absence of LIF. Knockdown of the positive control gene Mbd3 gave only a very minor increase in AP-positive colonies.  
(D) Microarray analysis shows that FGF4-deficient ES cells that have knockdown of Mp1 combined with FGF4 treatment have enhanced expression of the 
pluripotency genes Znf42 (Rex1), Esrrb, Sox2, and Tcl1 when compared with cells that were infected with control shRNAs and were treated simultane-
ously with FGF4. The dashed red stripes show standard deviations of duplicate experiments. (E) Titration of the PI3K inhibitor LY294002 showed enhanced 
resistance to this drug by cells with Mp1 knockdown. Increasing the LY294002 dose led to inhibition of phosphorylated Akt. CDK4 was used as a loading 
control. Error bars, standard deviation. Data represent two independent experiments. Bar, 100 µm.2682 Mp1 influences pluripotency | Westerman et al.
data) as compared with the shGFP control, suggesting that the 
cells lack the ability to respond positively to the FGF4 signal 
through the lack of phopho-Erk1/2 activation. In contrast, 
global phospho-Erk levels were only mildly affected by Mp1 
knockdown, although reduced levels were observed in Lamp1-
positive endosomes, as well as in cytoplasmic vesicles that lack 
Lamp1 expression (unpublished data). These data show that 
Mp1 knockdown does only mildly affect phospho-Erk levels 
in ES cells, which argues that the differentiation inhibitory 
effect of knockdown of Mp1 is therefore not likely to be a 
result of total ablation of Erk signaling but rather a result of 
modulation of the Erk signaling network that leads to differ-
entiation, possibly through endosomal signaling because Mp1 
localizes to late endosomes in ES cells (unpublished data).
In summary, our results indicate a bimodal action of Mp1 
in differentiation and proliferation of ES cells. Mp1 knock-
down directs FGF4 signaling toward self-renewal by tran-
scriptional activation of the self-renewal regulators Esrrb, 
Zfp42, Tcl1, and SOX2 and simultaneously enhances PI3K 
signaling  without  changing  the  responsiveness  to  FGF4-
mediated Erk2 phosphorylation. Our data therefore im-
plicate that the Mp1 knockdown rewires Ras–Mek–Erk 
signaling toward self-renewal without affecting the global 
Ras–Mek–Erk and PI3K signaling that contribute to the 
proliferative effect.
Results were confirmed by qPCR. Enhanced expression of 
Esrrb, Zfp42, Tcl1, and Sox2 is also observed when cells re-
main undifferentiated either by treatment of LIF or when 
treated without FGF4 (unpublished data).
Western blot detection of phosphorylated Akt shows that 
in the absence of PI3K-inducing ligands such as FGF4, LIF, 
and serum, the PI3K pathway is active (unpublished data). 
To analyze whether knockdown of Mp1 led to differences   
in PI3K signaling activity, we titrated the transduced cells 
with the PI3K inhibitor LY294002. This showed that knock-
down of Mp1 was able to generate a stronger resistance to 
LY294002-induced proliferation inhibition, which suggests 
that PI3K signaling levels are enhanced upon knockdown of 
Mp1 (Fig. 5 E).
Knockdown of Mbd3 is able to inhibit the differentia-
tion of ES cells, however, without showing the proliferation 
phenotype as seen with Mp1 knockdown. We used Mbd3 
knockdown as a control for FGF4-mediated proliferation/
differentiation experiments, and these cells were treated the 
same way as the Mp1 experiments and tested as to whether 
FGF4  stimulation  resulted  in  enhanced  self-renewal,  simi-
lar to what was observed for Mp1. In this case, however, 
we noticed no, or a very minor, effect of FGF4 to enhance 
self-renewal (Fig. 5 C). Notably, phospho-Erk1,2 levels were 
markedly lower in cells with Mbd3 knockdown (unpublished 
Figure 6.  GCTs of invasive EC and Sem show low expression of MP1. (A) Schematic outline of GCT progression. Primordial germ cells (PGCs) can 
progress into CIS which can give rise to Sem and/or EC, of which the latter can progress to Ter, CC, and YST. (B) Bar plot showing the relative RNA expres-
sion levels of MP1, OCT3/4, and NANOG in different stages of human GCTs as measured by qPCR. Horizontal lines represent the median value, boxes the 
upper and lower quartiles, and lines the maximal and minimal measured value. PGCs (n = 5) have lower expression of MP1 than CIS (n = 6; P < 0.05). CC 
(n = 3) and Ter (n = 6) have higher expression of MP1 than EC (n = 7) or Sem (n = 10; P < 0.05), similar to YS (n = 6), which has higher expression of MP1 
than Sem (n = 12; P < 0.05). (C) Immunohistochemistry shows that preinvasive CIS are positive for MP1, whereas both Sem and EC in the same specimen 
have low to undetectable levels of MP1. MP1 is expressed in differentiated components of Ter tumors in 15% of the patients. Panel A was adapted from 
R. Lothe, with permission. Bars 100 µm.JEM Vol. 208, No. 13 
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specimen contains tumor cells. CIS cells can progress into 
Sem and EC. Strikingly, none of the Sem (n = 48) and the 
majority of EC (n = 40) showed detectable expression of 
MP1, which was especially clear in tissues that represent mul-
tiple tumor stages (Fig. 6 C). Mp1 expression levels inversely 
correlated with NANOG and OCT3/4 mRNA expression 
levels in the invasive components (Fig. 6 B).
EC can differentiate into choriocarcinoma (CC), yolk sac 
tumor (YST), and teratoma (Ter). Although CC and YST 
showed low expression of Mp1 on the protein level (not de-
picted), some of the Ter samples (15%) that were analyzed   
(n = 124) expressed high levels of MP1 in differentiated 
tumor elements (Fig. 6 C and not depicted). In summary, we 
observed expression of Mp1 in all CIS samples of GCTs, and 
this expression was lost in the early invasive components after 
tumor progression, i.e., Sem and EC. This shows a correla-
tion between absence of expression of Mp1 and progression 
to invasive growth of GCTs.
EC and Sem have been shown to rely on autocrine FGF 
signaling for their self-renewal (Greber et al., 2007b). For early 
malignant cells to become invasive and less dependent on FGF 
ligands produced by the bulk of the tumor, we argued that low 
MP1 levels might, in analogy to the mouse ES cells, be able to 
direct FGF signaling toward self-renewal. To test this hypoth-
esis, we inhibited autocrine FGF signaling by the FGFR in-
hibitor SU-5402 and we simultaneously knocked down MP1. 
For this we used NCC-IT cells, which are considered to re-
flect a tumor progression stage between EC and Sem.
Addition of 30 µM SU-5402 to NCC-IT cells resulted in 
a clear induction of differentiation after 5 d of culture. Knock-
down of MP1 (Fig. 7 A) under these conditions was able to 
rescue SU-5402–mediated differentiation, as was observed 
EC and Sem GCTs show low expression of Mp1 and knockdown 
of Mp1 results in resistance to differentiation
GCTs  are  subdivided  into  Sem  and  non-Sem  tumors,  of 
which the latter can contain histologically undifferentiated 
elements composed of EC cells. A schematic representation 
of GCT progression is shown in Fig. 6 A. Because EC and 
Sem cells resemble ES cells (Andrews, 2002; Looijenga et al., 
2003; de Jong et al., 2008; Gillis et al., 2011), we reasoned 
that low levels of MP1 might resist differentiation cues and 
can thereby contribute to the progression of this tumor. We 
analyzed the expression of MP1 in different histological ele-
ments of GCTs using qPCR (Fig. 6 B) and immunohisto-
chemistry (Fig. 6 C; results are summarized in Table 2). The 
earliest developmental stage of GCT of the adult testis is car-
cinoma in situ (CIS; Oosterhuis and Looijenga, 2005). A set 
of CIS samples (n = 56) was analyzed and all showed expres-
sion of MP1. In all cases, strong expression of MP1 was seen 
in the tumor cells, whereas surrounding nontumorous tissue 
was negative. Note that mRNA levels underestimate the cel-
lular levels in CIS samples because only a subfraction of the 
Table 2.  Summary of Mp1 stainings on human GCT samples
Stage Number of samples Mp1 positive Fraction
%
CIS 56 56 100
Sem 48 0 0
EC 49 0 0
YST 65 0 0
CC 18 0 0
Ter 124 19 15
Figure 7.  Knockdown of MP1 in NCC-IT cells prevents differentiation. Knockdown of MP1 in NCC-IT cells (A) prevents differentiation as a result 
of SU-5402 treatment at 30 µM, as shown by AP staining (B), enhanced OCT3/4 mRNA expression, and enhanced numbers of cells AP-positive cells  
(C) with an undifferentiated morphology versus AP negative/weak cells with a differentiated morphology. Error bars, standard deviation. Bars, 100 µm.  
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directly control pluripotency (Boyer et al., 2005; Zhang et al., 
2008) and are able to induce induced pluripotent stem cells in 
conjunction with OCT3/4 (Takahashi and Yamanaka, 2006; 
Feng et al., 2009). In addition, Tcl1 and Zfp42 (Rex1) are 
enhanced by FGF4 in the absence of Mp1 and these genes 
enhance ES cell proliferation (Matoba et al., 2006) and pre-
vent germ layer commitment in ES cells (Scotland et al., 
2009), respectively.
It has been described that HrasV12 overexpression in ES 
cells and mouse EC cells results in differentiation, even in the 
presence of LIF. Overexpression of KrasV12, Eras, and Nras 
primarily leads to a proliferation phenotype (Takahashi et al., 
2003; Quinlan et al., 2008). We show that Mp1 knockdown 
primarily  affected  HrasV12-induced  differentiation,  which 
suggests that HrasV12 specifically triggers a portion of Ras/
Mapk signaling that leads to differentiation. Indeed, HrasV12 
induces a strong Mapk signal as seen from high phospho-
Erk1/2 levels after infection of ES cells (unpublished data). 
Erk2 is the downstream target of the Mapk pathway in ES 
cells (Kunath et al., 2007). FGF4- and Erk2-deficient ES cells 
have been shown to be unable to commit to mesodermal and 
endodermal fates (Kunath et al., 2007). However, in both 
cases there is no activation of the Ras–Mapk–Erk pathway, 
resulting in a poor proliferation, consistent with data of Ying 
et al. (2008). Several scaffolds are known which regulate the 
activation of Mapk–Erk on distinct subcellular compartments 
(focal adhesions, Golgi, plasma membrane, and early endo-
somes) in mammalian cells (Dhanasekaran et al., 2007; Pullikuth 
and Catling, 2007). Study of the intrinsic differences of dif-
ferent Ras isoforms has revealed that posttranslational modi-
fications of their C termini has functional consequences, 
leading to palmitoylation (Hras, Nras, and Kras4A) or only 
farnesylation and geranylation (Kras 4B; Konstantinopoulos 
et al., 2007). Palmitoylation of Hras, Nras, and Kras4A is be-
lieved to result in different trafficking within microdomains 
of the membranes (Hancock, 2003). These data indicate 
that the intracellular localization of the Ras–Mek–Erk signal 
might play a causal role in the differentiation-inducing ability 
of these Ras members. Hras has been shown to enter the 
endocytic compartment and its return to the membrane de-
pends on the endocytic recycling pathway (Roy et al., 2002; 
Gomez and Daniotti, 2005). Ubiquitination of Hras stabilizes 
its association with endosomes (Jura et al., 2006). This is in 
contrast to Kras, which only minorly and transiently associ-
ates with the endosomes (Roy et al., 2002). Because Mp1 is 
localized to the late endosomes, the loss of the small fraction 
of late endosomal activated Erk in ES cells might not be able 
to change the global levels of phospho-Erk, although we no-
ticed that the intracellular localization of phospho-Erk was 
affected by Mp1 knockdown after FGF4 stimulation, result-
ing in reduced levels of phospho-Erk in Lamp1-positive 
endosomes and lipid rafts throughout the cell.
There are at least two stages in early embryogenesis where 
FGF signaling plays a significant role, i.e., in the epiblast stem 
cells stage and during gastrulation. Mouse epiblast-derived 
stem cells (EpiSCs), i.e., cells derived from the epiblast of the 
by reduced levels of protruding differentiating cells from the 
EC colonies resulting in sharp edged colonies. In addition, we 
saw that these cells show up-regulated OCT3/4 levels upon 
MP1 knockdown (Fig. 7 C, top) and showed increased num-
bers of AP-positive colonies (Fig. 7 B, quantified in Fig. 7 C), 
showing that MP1 knockdown results in enhanced levels of 
self-renewal under differentiation inducing conditions.
In summary, we show that low MP1 levels, as observed 
in post-CIS–stage GCTs does not only correlate with undif-
ferentiated and invasive components of GCTs but also con-
tributes to prevention of differentiation of EC/Sem cells under 
conditions that induce differentiation of these cells. Together, 
our results show that knockdown of MP1 is able to inhibit 
differentiation of ES cells as well as GCTs.
DISCUSSION
In this paper, we describe the results of a knockdown screen 
in mouse ES cells to identify factors required for differentia-
tion. Grouping of the identified genes into functional path-
ways shows that multiple hits are involved in Ras–Mek–Erk 
signaling. EphB4 receptors can regulate the activity of the 
Ras family of GTPases, including H-Ras and R-Ras (Zou et al., 
1999; Miao et al., 2001; Wang et al., 2006). When Ptpn11 
(also called Shp-2), another hit from our screen, was pre-
vented from interacting with a mutated gp130 receptor that 
failed to activate ERKs, this led to self-renewal (Burdon et al., 
1999). These data show that our unbiased, genome-wide 
knockdown approach identified several factors that were 
previously identified to be important in self-renewal of ES 
cells and validate our screening strategy. An shRNA against 
Capn10 was found in 50% of the sequences and, when 
tested individually, this shRNA showed strong ES colony 
outgrowth during the first 2 wk after removal of LIF. During 
the 3rd wk however, this proliferation declined and most 
cells died. This indicates that knockdown of Capn10 gives a 
phenotype distinguishable from other hits such as shMp1 or 
shPtpn11, which gave prolonged pluripotency throughout 
the course of the experiment. Among the candidate hits, we 
identified MP1 as a mediator of differentiation of ES cells, 
and knockdown of this gene prevents differentiation of ES 
cells. The phenotype observed was the strongest among all 
other identified hits.
Mouse ES cells differentiate when LIF is removed from 
the medium, when Bmp4 is removed from the medium in the 
presence of LIF, when cells are stimulated with FGF4 in the 
absence of LIF, and when HrasV12 or Braf   V600 are overex-
pressed. We show that all these differentiation-inducing cues 
can be inhibited by Mp1 knockdown.
Fgf4 signaling leads to differentiation of ES cells (Kunath 
et al., 2007) and it also enhances proliferation of the differen-
tiating ES cells. We observed that knockdown of Mp1 re-
sulted in increased proliferation upon stimulation with FGF4, 
but without induction of differentiation, showing that knock-
down of Mp1 results in uncoupling between proliferation 
and differentiation in ES cells. We show that Sox2 and Esrrb 
are up-regulated by FGF4 in the absence of Mp1. These genes JEM Vol. 208, No. 13 
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toward self-renewal in the invasive GCT stages Sem and EC. 
We show that knockdown of Mp1 in NCC-IT cells results 
in inhibition of differentiation after treatment of the cells by 
SU-5402. Mouse ES cells can self-renew under high levels of 
FGF4 signaling (unpublished data), which indicates that the 
signaling pathways that determine differentiation and self-
renewal might have a shifted balance in GCTs when com-
pared with mouse ES cells. Our results indicate that inhibition 
of Mp1 could be part of a common mechanism that main-
tains self-renewal of GCTs. The data indicate that Mp1 down-
regulation is not required to maintain an embryonic germ 
cell phenotype in the niche of Sertoli cells, although this is 
needed in the invasive tumors. This might elegantly explain 
why CIS cells are, in principle, able to differentiate to all lin-
eages upon leaving their specific niche (i.e., interaction with 
the basal lamina and Sertoli cells). In fact, in spite of this in-
trinsic pluripotency, they do not differentiate in their pre-
invasive niche.
In conclusion, by performing an unbiased genome-wide 
shRNA screen, we have identified the scaffolding protein 
Mp1 as a critical factor that can determine whether FGF4–
Ras–Mek–Erk signaling results in differentiation or pluripo-
tency in mouse ES cells while maintaining Erk2 and PI3K 
signaling. Our results show that knockdown of Mp1 can 
overrule the differentiation-inducing signal from FGF4/Ras 
signaling by activation of pluripotency regulators. Knock-
down of MP1 in NCC-IT GCT cells is able to partially block 
the differentiation of these cells. Our results shed new light 
on the FGF signaling in the early stages of mouse embryo-
genesis and provide insight on the role of MAPK scaffolding 
proteins in cancer.
MATERIALS AND METHODS
ES cell culture. E14T (Li et al., 1998), F1V6.5, and E14/Tg2a ES cells 
were cultured on gelatin-coated tissue culture plastic. E14/Tg2a ES cells lack   
the constitutively expressed polyoma large T from an expression cassette 
pMGDneo20 (Gassmann et al., 1995) that is expressed in E14T cells to en-
able episomal replication of pPyCAGIP expression vectors. The E14T and 
FGF4/ cells, based on the R1 mESC line (Wilder et al., 1997), were ob-
tained from the Austin Smith laboratory with permission of M. Capecchi 
(Howard Hughes Medical Institute, University of Utah, Salt Lake City, UT) 
for the latter cell line. Cells were grown in 60% buffalo rat liver conditioned 
(BRL) medium plus LIF (60% BRL, 40% LDM medium, including 2 mM 
l-glutamine [Invitrogen], 0.1 mM 2-mercaptoethanol, and 10 U/ml LIF 
[ESGRO LIF; Millipore]). LDM consists of GMEM (Glasgow Modified 
Eagle Medium), 2 mM l-glutamine (Invitrogen), 1 mM sodium pyruvate 
(Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 10% FCS (PAA; 
Pasching), 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). 
BRL was obtained by collecting LDM that was conditioned for 1 wk onto 
Buffalo Rat Liver cells. For serum-free culture of ES cells, N2B27 medium 
(Li et al., 1998; Ying et al., 2003), including 10 U/ml LIF and 10 ng/ml 
Bmp4 (R&D Systems), was used.
Ethics statement. All animal experiments were approved by the advisory 
board for animal experimentation of the Medical University of Innsbruck 
and by the Austrian ministry for Science and Research based on the Austrian 
Animal Testing Act of 1988. Use of the patient tissues is approved by an in-
stitutional review board (MEC 02.981). Samples are used according to the 
Code for Proper Secondary Use of Human Tissue in the Netherlands, from 
the Dutch Federation of Medical Scientific Societies (FMWV; version 2011).
early postimplantation mouse embryo, share similarities with 
human ES (hES) cells (Brons et al., 2007; Tesar et al., 2007). 
These cells require FGF signaling for their self-renewal in 
addition to Activin A/Smad2-3 signaling (Vallier et al., 2005; 
Xu et al., 2005; Greber et al., 2007a, 2010; Xu et al., 2008). 
FGF signaling enhances Nanog expression in hES cells (Ludwig 
et al., 2006; Li et al., 2007) and prevents activation of neural 
differentiation genes in EpiSCs (Greber et al., 2010). This is 
consistent with a recent study showing that lowering FGF 
signaling in mouse ES cells after initial FGF-mediated differ-
entiation leads to enhanced differentiation (Stavridis et al., 2010). 
These data indicate that low Mp1 levels might, together with 
Activin/Smad2-3 signaling, lead to a maturation arrest in the 
EpiSC stage. However, high expression of the inner cell mass 
marker Zfp42/Rex1 (Fig. 5 D; Rathjen and Rathjen, 2003), 
positive staining for AP, and the virtual absence of the epiblast 
marker FGF5 (not depicted; Rathjen et al., 1999) indicates that 
Mp1 knockdown does not result in an EpiSC maturation 
arrest.
The second step where FGF/Ras/Mapk signaling plays a 
role during early embryogenesis is during gastrulation. In this 
process, cells of the primitive streak undergo a Ras/MAPK 
governed epithelial to mesenchymal transition (EMT) and dis-
ruption of FGF8-, FGFR1-, or MAP4K4-mediated signaling 
results in inhibition of this EMT process and, therefore, meso-
derm formation is inhibited (Yamaguchi et al., 1994, Sun et al., 
1999; Ciruna and Rossant, 2001; Xue et al., 2001). Therefore, 
low Mp1 levels in combination with FGF signaling might cre-
ate a nonpermissive state to adapt to a mesodermal program, 
possibly overlapping with processes that occur in the primitive 
streak, i.e., through an inability to enter a MAPK-governed 
EMT program. In this context, it is interesting to note that 
LIF/STAT3 treatment resulted in repression of many regulat-
ing genes of the Ras–Mapk pathway (unpublished data), indi-
cating that LIF/STAT3 signaling could functionally overlap 
with the effect of Mp1 knockdown.
The phenotype observed with loss of Mp1 does partially 
overlap with loss of p14, the heterodimerizing partner of 
Mp1 (unpublished data). In short-term assays, knockdown of 
p14 resulted in a maturation arrest similar to Mp1 knock-
down; however, secondary lethal effects prevent a long-term 
effect in vitro and in vivo. These data suggest that the func-
tions of Mp1 and p14 have only a limited overlap in ES cells. 
This is consistent with earlier studies, which have shown that 
mice deficient for p14 and p18 die because of growth retar-
dation with severe developmental defects (p14; Teis et al., 
2006) and defects in the organelle organization of the visceral 
endoderm (p18; Nada et al., 2009).
Human EC cells have an FGF2-dependent self-renewal 
program (Greber et al., 2007b) and murine EC cells are 
blocked in their differentiation by activin A (van den Eijnden-
van Raaij et al., 1991). Mp1 is absent or expressed on a low 
level in any of the invasive GCTs with the histology of Sem 
and EC (except some Ters, YST, and CC), whereas it is posi-
tive in all non invasive CIS samples. We hypothesized that 
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marker of undifferentiated ES cells (Sigma-Aldrich). Alternatively, the pro-
tocol was reduced to a 2-wk differentiation protocol by refreshing the me-
dium at days 5 and 12. The shMp1 phenotype was confirmed with two 
independent mouse ES cell lines: F1V6.5 and E14/Tg2a. In both cases, cells 
were seeded at 40,000 cells per well and treated as in the previous section.
To induce neural differentiation of ES cells, cells were grown in serum-
free medium (N2B27; Li et al., 1998; Ying et al., 2003), including 10 U/ml 
LIF but excluding Bmp4 for 1 wk. Cells were then replated, and this resulted 
in neurosphere formation during this 2nd wk of culture. Cells were plated 
on poly-ornithine and laminin-coated plates to grow them as a monolayer. 
To measure the effect of FGF4 on differentiation, FGF4-deficient ES cells 
were grown overnight in serum-free medium (N2B27), including Bmp4 at 
10 ng/ml, and treated with FGF4 at a concentration of 20 ng/ml for 5 d 
after. ES cells were visualized with the AP staining kit.
A Nanog-GFP reporter construct was made in a pACGFP1-1 vector 
(Takara Bio Inc.) based on Rodda et al. (2005). Primers for amplification of 
the mouse 289 to +177 Nanog fragment were (with restriction sites for 
cloning purposes indicated in lowercase): Nanog 289 forward, 5-CGC-
gtcgacTAAAGTGAAATGAGGTAAAGCC-3; and Nanog +177 reverse 
5-CGCggatccGGAAAGATCATAGAAAGAAGAG-3. An ES cell clone 
that had stably integrated the reporter construct was selected and used in 
subsequent reporter assays. For differentiation, cells were seeded at 40,000/
well of a 6-well plate in LDM medium. Medium was refreshed every day. 
At day 4 after seeding, the GFP levels of the cells were analyzed using a 
FACSCalibur and plotted in graphs.
To analyze whether undifferentiated ES cells have a proliferation advan-
tage upon knockdown of Mp1 versus the control hairpin shRnd1, Nanog-
GFP reporter cells were treated in LDM for 4 d, as in the previous paragraph, 
pulsed with 10 µM BrdU for 1 h, and then FACS sorted. The populations 
with highest versus the lowest Nanog-GFP expression (both representing 
10% of the viable population) were analyzed. Cells were fixed in 70% etha-
nol and permeabilized with 5 M HCl and 0.5% Triton X-100 for 20 min, 
followed by neutralization with 2/5-vol 0.1 M Na2B4O7. Cells were treated 
with anti-BrdU antibody (Dako M074402) for 30 min and subsequently 
with anti–mouse IgG–Alexa Fluor 568 (Invitrogen) for 30 min. DNA was 
counterstained with TO-PRO3 (Invitrogen T3605) to exclude cell clumps 
from the analysis. Statistical analysis was done using a Student’s t test.
EC cells use autocrine FGF signaling for their self-renewal program 
(Greber et al., 2007b). To differentiate NCC-IT cells (Damjanov et al., 
1993), which are considered equivalent to a stage intermediate between Sem 
and embryonal carcinoma, cells were transfected with a stealth siRNA 
against MP1 or a mock siRNA using Lipofectamine, or cells were infected 
with an shRNA against MP1 (Sigma-Aldrich) or a mock shRNA vector 
(SHC002; Sigma-Aldrich). Sequences are shown in Table S1. After selection 
on puro (in case of the infection) at 2 µg/ml, cells were seeded in 6-well 
plates at a density of 25,000 cells/well, and cells were subsequently treated 
for 5 d with 30 µM of the FGFR inhibitor SU-5402, followed by AP stain-
ing and quantification as in the first paragraph of this section, as well as 
qPCR analysis for NANOG and OCT3/4 (primers listed in Table S2).
Immunostainings.  Immunofluorescence  was  performed  by  fixing  cells 
onto gelatin-coated permanox chambers in 4% paraformaldehyde. Anti-
bodies used were anti-V5 (R960-25; Invitrogen), anti-OCT3/4 (C10; Santa 
Cruz Biotechnology, Inc.), anti-nestin (611658; BD), anti–tubulin-III 
(Sigma-Aldrich), anti–phospho-ERK1/2 (Cell Signaling Technology), and 
anti–mouse CD107a (lysosomal associated membrane protein 1 [LAMP1]; 
BD). Secondary antibodies were anti–mouse IgG Cy3 (Jackson Immuno-
Research Laboratories). Alexa Fluor 568 anti–rabbit (Invitrogen), Alexa Fluor 
568 anti–mouse (Invitrogen), or Alexa Fluor 647 anti–mouse (Invitrogen). 
DAPI was obtained from Sigma-Aldrich and Alexa Fluor 488–Phalloidin 
from Invitrogen. As a positive control for the nestin staining, we used post-
natally derived subventricular zone neural stem cells.
For  localization  analysis  of  phospho-Erk,  E14T  shMP1  and  E14T 
shRnd cells were kept in 60% BRL + -mercaptoethanol + LIF and seeded 
on glass slides which were coated with 0.1% gelatin (Millipore) for 4 h. 
Genome-wide knockdown screen. We used the NKI shRNA library tar-
geting 16,000 mouse genes, which contains at least two specific hairpins for 
each gene (library construction is described by Huang et al., 2009). We based 
our protocol on the screen protocol by Chambers et al. (2003), which uses 
differentiation induction by removal of LIF from the medium. To ensure that 
the full library was represented, we used a 100-fold excess of the library com-
plexity. Cells were transduced with the pooled shRNA library or with the 
pRS-shGFP negative control simultaneously (the shRNA sequences is shown 
in Table S1). Cells were also electroporated with pCAG-Nanog control (posi-
tive control) or with a pCAG-empty control (negative control). 3.2 million 
cells were replated at a clonal density of 200,000 cells per 180-cm2 dish (17 
plates). The next day, the cells were washed twice with LDM medium to re-
move LIF and the cells were cultured in the absence of LIF for 1 wk. Cells 
were replated at the same density every 7 d for a total of 22 d. Colonies were 
counted after 13 (second round) and 20 (third round) d of culturing. After 
22 d of culture in the absence of LIF, the cells were harvested and genomic 
DNA was isolated.
Identification  of  shRNA  cassettes. The shRNA cassettes were recov-
ered from isolated genomic DNA or plasmid by PCR using the Expand 
Long  Template  polymerase  kit  (Roche)  and  the  following  primers  using 
an annealing temperature of 62°C: 312-MSCVPuro-seq5MCS, 5-CTT-
GAACCTCCTCGTTCGACC-3;  374-MSCV,  5-CTAAAGCGCAT-
GCTCCAGACTG-3. The inserts were checked for their lengths (643 bp). 
The inserts were then digested with the EcoRI–XhoI restriction enzymes ob-
taining a 301-bp fragment containing the H1 promoter and shRNA sequence. 
The obtained fragments were then cloned back into the pRetrosuper plasmid 
using ElectroMAX DH10 cells. Samples with genomic DNA from unin-
fected cells and an H2O control were included to check for any contamination 
in the PCR reactions. 300 colonies were sequenced (shRNA sequences are 
shown in Tables S3 and S4).
ES cell knockdown and overexpression experiments. Retroviral deliv-
ery of pRS-shRNA was performed by performing four 5–6-h rounds of infec-
tion, followed by selection on 4 µg/ml puromycin. All knockdown experiments 
were done using these conditions. E14T cells were seeded at 40,000–80,000 per 
well in 6-well plates. The next day, retrovirus (collected in LDM) was mixed 
1:1 with infection medium (100% BRL, 20 U/ml LIF, 4 mM l-glutamine, 
0.2 mM 2-mercaptoethanol, and 1.6 µg/ml polybrene) and put on cells in 
duplicate. Medium was replaced by 60% BRL plus LIF and incubated over-
night. All shRNAs were cloned into pRetrosuper according to standard pro-
cedures. As negative controls for the knockdowns, shGFP and random shRNA 
(shRnd) were designed (Table S1). Knockdown was measured by qPCR using 
SYBR Green PCR Master Mix (Applied Biosystems) using Actin or Hprt 
housekeeping primers as a reference. Primers are listed in Table S2.
For overexpression of HrasV12 and Braf   V600, we used the MSCV-blast-
HrasV12 and MSCV-Blast-Braf   V600 constructs made by Chrysis Michaloglou 
(Department of Molecular Genetics, Netherlands Cancer Institute). MSCV-
blast-Kras was cloned from the pBabe K-Ras V12 construct (Addgene) from 
BamHI into the BglII sites of MSCV-Blast. These overexpression constructs 
were used to infect ES cells twice. Infected cells were selected with 5 µg/ml 
blasticidin for 4–6 d and plated at 8,000 or 40,000 per 24- or 6-well plates, re-
spectively. Cells were analyzed at days 5 and 6 and stained with AP (see ES/EC 
differentiation assays).
cDNAs encoding Mp1 and p14 were cloned into pLenti6V5/Dest vec-
tor by Gateway cloning from pENTR constructs, which were provided by 
M. De Araujo (Huber laboratory, Innsbruck Medical University, Innsbruck, 
Austria). ES cells were infected with a multiplicity of infection of 1. Cells 
were analyzed at days 6 and 14 for differentiation.
ES/EC differentiation assays. After infection with shRNA viruses fol-
lowed by 3 d of puromycin selection, E14T ES cells were seeded into 6-well 
plates at a density of 10,000/well. The next day, cells were cultured in LDM. 
At day 7, cells were replated at 10,000 per well and cultured for another 
week. This was repeated at day 14. At day 21, cells were stained for AP, a JEM Vol. 208, No. 13 
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